Today: 20 May 2026
Alien-signal hunt finds nothing from interstellar comet 3I/ATLAS after Green Bank scan
5 January 2026
2 mins read

Alien-signal hunt finds nothing from interstellar comet 3I/ATLAS after Green Bank scan

NEW YORK, Jan 5, 2026, 04:15 ET

  • Breakthrough Listen researchers reported no credible radio “technosignatures” from interstellar comet 3I/ATLAS
  • The null result lands amid heightened scrutiny of the comet’s unusual jet features seen in Hubble images
  • Scientists caution that radio silence narrows possibilities but does not answer every question about the object

A search for possible technosignatures — potential signs of advanced technology — in the interstellar comet 3I/ATLAS found no credible radio transmissions, Breakthrough Listen researchers reported. The team said its campaign detected no candidate signals down to the 100 milliwatt level.

The finding matters because 3I/ATLAS is a rare visitor from outside the solar system, and scientists had a limited window to scrutinize it as it swept past Earth. NASA says the comet posed no threat and came no closer than about 270 million km (170 million miles), after being reported to the Minor Planet Center on July 1, 2025 by the NASA-funded ATLAS survey in Chile.

Interest has stayed high partly because researchers are still trying to pin down how interstellar comets behave when sunlight starts driving off gas and dust. In a recent Medium post, Harvard astrophysicist Avi Loeb pointed to processed Hubble images that he said showed a long sunward “anti-tail” and a smaller, three-pronged inner jet pattern, and he asked whether the geometry might point to something beyond ordinary comet activity.

The Green Bank Telescope run lasted about five hours on Dec. 18, and observers alternated between the comet and nearby sky positions in what is known as an ABACAD arrangement — a switching pattern used to weed out interference, ScienceAlert reported. “This object is a comet,” NASA associate administrator Amit Kshatriya said in a November briefing, according to the report. ScienceAlert

Technosignature searches typically focus on narrowband radio signals — tight spikes in frequency that are efficient for long-distance communication and uncommon in natural astrophysical processes. In practice, the work often becomes a battle against radio-frequency interference: the hum of satellites, aircraft and terrestrial transmitters that can masquerade as something more exotic.

More interstellar visitors may not stay rare for long. The NSF–DOE Vera C. Rubin Observatory, which released its first images in June 2025, is preparing for its decade-long Legacy Survey of Space and Time, expected to accelerate discoveries of fast-moving objects that require rapid follow-up.

The comet has also spilled into broader debate about preparedness and priorities. In an opinion post on The Times of Israel’s blog, writer Rafi Glick called 3I/ATLAS a “wake-up call” and argued for a global framework to respond to interstellar objects, alongside more investment in observation and space exploration. The Times of Israel Blogs

The episode echoes earlier bursts of speculation around ʻOumuamua in 2017 and comet 2I/Borisov in 2019, the only other confirmed interstellar objects seen in the solar system. NASA officials have previously pushed back on the latest conjecture, saying the object’s trajectory and comet-like behavior point to a natural body on a hyperbolic orbit — an open path that will take it out of the solar system.

But the Green Bank result is not a comprehensive audit. The observations were a snapshot, and interference can overwhelm weaker signals; meanwhile, small differences in image processing can amplify or mute subtle structures in a comet’s coma and jets.

Stock Market Today

  • TAT Technologies (TATT) Beats Q1 Earnings and Revenue Estimates
    May 20, 2026, 9:58 AM EDT. TAT Technologies Ltd. (TATT) reported Q1 earnings of $0.26 per share, surpassing the Zacks Consensus Estimate of $0.19, a 40.54% positive earnings surprise. Revenues reached $41.15 million, beating estimates by 2.7%. Despite the upside, shares have declined 26.8% year-to-date, underperforming the S&P 500's 7.4% gain. The company operates in the Aerospace - Defense Equipment sector, currently ranked low by Zacks. The stock holds a Zacks Rank #5 (Strong Sell) ahead of the earnings report, reflecting unfavorable earnings estimate revisions. Consensus for the next quarter is $0.29 EPS on $46.09 million revenue. Investor focus will be on management's outlook and industry trends influencing future performance.

Latest articles

Vida’s $15 Million AI IPO Faces Its First Reality Check as CEO Buys In

Vida’s $15 Million AI IPO Faces Its First Reality Check as CEO Buys In

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Gold price today jumps on Venezuela shock as traders eye U.S. jobs data
Previous Story

Gold price today jumps on Venezuela shock as traders eye U.S. jobs data

Brand Engagement Network (BNAI) stock rises again premarket as AI pharma deal keeps traders hooked
Next Story

Brand Engagement Network (BNAI) stock rises again premarket as AI pharma deal keeps traders hooked

Go toTop